Webinar – Future-proof your drug development investment with robust IP search strategies

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Webinar – Future-proof your drug development investment with robust IP search strategies

Sponsored by

Logo 22.07.22.png
article banner@2x.png

Join Managing IP and CAS for a webinar at 5pm BST (12pm ET, 6pm CEST) on July 24 to learn how a strong intellectual property search strategy can ensure your pharmaceutical substance succeeds where others fail

A lack of novelty from the initial patent filing to post-grant actions such as inter partes review or infringement litigation can cause you to lose time and money.

How do you beat these odds? Plan for a professional search upfront to improve your chance of your patent being granted and enforceable.

In this webinar, experts Anne Marie Clark, Ph.D., senior patent searcher at CAS, and Heidi Berven, Ph.D., a partner at Honigman, will share best practices for intellectual property (IP) searching, including:

  • Essential novelty searches for pharmaceutical substances;

  • Tips for advanced IP search strategies and how they help to protect your research investment; and

  • The importance and hallmarks of trustworthy IP tools and partners.

Register here to level up your pharmaceutical IP search strategy.

more from across site and SHARED ros bottom lb

More from across our site

Mehmet Gün and Uğur Aktekin discuss four decades of change in Türkiye’s legal market, the firm’s commitment to independence and the challenge of building an institution that can outlast its founders
Boehringer Ingelheim has instructed a team from Kirkland, while Teva is being represented by Pinsent Masons
The Delhi High Court’s latest directions offer an opportunity to move beyond remedies against bad-faith registrations and address how suspicious applications are identified in the first place, says Fatima Baig at Lexlinc
Camilla Hamrin describes how the acquisition by Acapo Onsagers will impact Bergenstråhle’s trademark practice – and reflects on changes she has seen over 30 years in IP
On a recent trip to the French capital, we learned that the UPC is squeezing domestic litigation while firms are chasing senior talent, experimenting with AI and considering new ways of organising their practices
Daniel Law says a string of lateral hires and broader expansion plans will strengthen its position to capitalise on Brazil’s burgeoning IP and patent litigation market
Jason Raeburn’s arrival will expand the firm’s London footprint in AI, copyright and tech disputes
The firm is shaping its AI strategy around partnerships with Harvey and Legora alongside internally developed tools from its legal technology company, Eltemate
A dispute Down Under shows why trademark lawyers cannot afford to wait on the sidelines when a rival brand gathers momentum
The Third Circuit’s decision in Thomson Reuters v ROSS marks the first appellate-level decision addressing AI and fair use, prompting copyright counsel to consider arguments around potential licensing markets
Gift this article